IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction
2015 · Nature Immunology · 434 citations
https://doi.org/10.1038/ni.3103
I
Ina Rudloff
Hudson Institute(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
38
Papers
1.9K
Citations
19
h-index
23
i10-index
Ina Rudloff is an academic researcher from Hudson Institute. The author has contributed to research in topics: Neonatal Respiratory Health Research & Psoriasis: Treatment and Pathogenesis & Dermatology and Skin Diseases. The author has an h-index of 19, co-authored 33 publications.
ORCID: 0000-0002-7885-110XPapers by this author
worksRemifentanil ameliorates intestinal ischemia-reperfusion injury
2013 · BMC Gastroenterology · 54 citations
https://doi.org/10.1186/1471-230x-13-69
Airway Remodeling and Hyperreactivity in a Model of Bronchopulmonary Dysplasia and Their Modulation by IL-1 Receptor Antagonist
2016 · American Journal of Respiratory Cell and Molecular Biology · 53 citations
https://doi.org/10.1165/rcmb.2016-0031oc
Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study
2012 · BMC Medicine · 52 citations
https://doi.org/10.1186/1741-7015-10-102
Rare variants in non-coding regulatory regions of the genome that affect gene expression in systemic lupus erythematosus
2019 · Scientific Reports · 23 citations
https://doi.org/10.1038/s41598-019-51864-9
Mechanisms of Rapid Induction of Interleukin-22 in Activated T Cells and Its Modulation by Cyclosporin A
2011 · Journal of Biological Chemistry · 19 citations
https://doi.org/10.1074/jbc.m111.286492
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat